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Edited by Ulf-Ingo Fl€uggeAbstract We have used cationic oligopeptide polyarginine-
12mer (POA) to deliver double-stranded RNA (dsRNA),
prepared in vitro, to tobacco (Nicotiana tabacum) suspension
cells. POA interacts electrostatically with dsRNA to form a
complex. When dsRNA for the GUS or NPTII gene was
delivered into cells carrying the same genes, the corresponding
mRNA was degraded. Using RNase protection assay we were
able to detect 21-bp small interfering RNA in dsRNA/POA-
treated cells. These results demonstrate that POA can be used to
deliver dsRNA to induce post-transcriptional gene silencing in
plant cells.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
Keywords: Polyarginine; Double-stranded RNA;
Post-transcriptional gene silencing; RNase protection assay1. Introduction
Post-transcriptional gene silencing (PTGS) in plants and
RNA interference in animals and protozoa, collectively known
as RNA silencing, share many components needed to degrade
the mRNA homologous to the double-stranded RNA
(dsRNA) applied. RNA silencing is thought to be involved in
certain developmental or physiological processes in addition to
its role in cellular resistance to viral RNA. It has been shown
to be eﬀective in a number of organisms including Drosophila
[1,2], nematodes [3,4], trypanosomes [5], mammals [6] and
plants [7,8]. dsRNA, either formed intracellularly or delivered
exogenously, plays a central role in triggering degradation of
the target mRNA. The dsRNA is cleaved into 21–23 nt small
interfering RNA (siRNA) which binds to the RNA-induced
silencing complex, also called as RISC, that recognizes theq This work has been supported by the BioGreen Research Fund,
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dependent RNA polymerase (RdRp) to maintain an excess
molar ratio over the target mRNA [13]. In order to investigate
certain aspects of siRNA ampliﬁcation in plants, we have
sought a procedure by which dsRNA, prepared in vitro, can be
eﬀectively delivered into plant cells.
In animal systems, dsRNA is introduced either by injec-
tion [3] or by feeding cells in dsRNA-containing medium
[14,15]. PTGS has been studied mostly by transforming
plants with dsRNA-forming vectors for the selected gene by
Agrobacterium [7,8,16,17], by bombardment [18], by inﬁl-
tration [19], or by infecting plants with viral vectors that
produce dsRNA [20]. In addition, Agrobacterium-mediated
transient expression was successfully adopted to study PTGS
in the intact tissues without generating transgenic plants
[21]. Most of these methods require vector construction and
plant transformation. In this study, we have developed a
cationic oligopeptide to eﬃciently deliver dsRNA into plant
cells.
POA is a modiﬁed form of the protein transduction domain
(PTD) of the various proteins, including the human immunode-
ﬁciency virus-tat transcription factor [22]. PTD in general con-
tainsmany cationic amino acids, such as arginine or lysine,which
are known to play an important role in transverse cell membrane
[23]. A b-galactosidase polypeptide, translationally fused to a
PTDsequence,was successfullydelivered to themost tissues after
intraperitoneal injection of mice [24]. It was recently found that
due to its cationic nature, PTD can also interact electrostatically
with DNA, and that the resulting complex was shown to be de-
livered eﬀectively intomammalian cells [25,26]. In viewof the fact
that both dsRNA and DNA are negatively charged, we chose a
synthetic cationic homoarginine oligopeptide 12-mer, POA, to
deliver dsRNA into tobacco cells to induce PTGS.2. Materials and methods
2.1. Plant material
Tobacco suspension cells (Nicotiana tabacum cv. Petit Havana) were
derived from the shoots of transgenic tobacco plants that had been
transformed by Agrobacterium with the plasmid pBI121 carrying the
GUS and NPTII genes, which were placed downstream of the pro-
moters of 35S and nopaline synthase, respectively. The culture was
maintained in the Murashige and Skoog (MS) medium containing 3%
sucrose, 2 mgml1 2,4-D, 1 mgml1 kinetin and 50 lgml1 kana-
mycin. The culture was routinely transferred to 40 ml MS medium
every week and was grown in the dark with gentle shaking (100 ro-
tations per minute (rpm)) at 25 C.ation of European Biochemical Societies.
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To prepare dsRNA, DNA templates were ampliﬁed by PCR, in-
troducing T7 RNA polymerase binding sequences at the 50 end of the
both strands. The 0.9- and 0.4-kb internal regions of GUS and NPTII
coding sequences, respectively, were ampliﬁed. The products were
transcribed in both the directions by T7 RNA polymerase using the
Megascript T7 Transcription Kit (Ambion, USA) to generate both
sense and antisense RNAs. After the DNA templates were removed by
DNase, RNA was puriﬁed by phenol–chloroform extraction and was
precipitated by ethanol. The resulting pellet was suspended in DEPC-
treated water and annealed into dsRNA at 65 C. The dsRNA was
quantiﬁed using GeneQuant (Pharmacia Biotech, USA) and stored at
)20 C.
2.3. Preparation and delivery of ﬂuorescein isothiocyanate-dsRNA
To prepare ﬂuorescein isothiocyanate (FITC)-dsRNA (GUS),
dsRNA was prepared as described above, except that aminoallyl UTP
(Sigma, USA) was included instead of UTP. FITC was then conju-
gated to the dsRNA by mixing and stirring the dsRNA with 150 lg
FITC/mg dsRNA in bicarbonate buﬀer (pH 9.5) at 4 C overnight. The
FITC-dsRNA was precipitated with sodium acetate/ethanol and pu-
riﬁed via a Sephadex G-50 column. The FITC-dsRNA thus prepared
was complexed with POA before being delivered to cells.
2.4. Formation of dsRNA/POA complex
POA was commercially synthesized (Peptron Inc., Korea). POA was
dissolved in phosphate-buﬀered saline (PBS, pH 7.4) at a concentra-
tion of 200 lM and aliquots were frozen at )70 C until use. To de-
termine the optimal binding ratio of dsRNA to POA, 100 ng of
dsRNA (GUS) was mixed with the various concentrations of POA (5,
10, 15, 20, 25, 37.5 and 50 ng) in PBS buﬀer to a ﬁnal volume of 10 ll
and incubated on ice for 30 min and electrophoresed in 1% agarose gel.
The point at which the dsRNA disappeared was taken as the optimum
amount of POA and was scaled up for further studies. The optimum
concentration of POA for dsRNA (NPTII) was determined in the same
way.
2.5. Delivery of dsRNA/POA complex to suspension cells
Various concentrations of dsRNA of GUS or NPTII (1, 5, 10 and 20
lg) were mixed with POA and the dsRNA/POA complex was delivered
to suspension cells. MS medium was removed from 5 ml of 3-day-old
suspension cell (approximately 1 g fresh cell) and cells were rinsed with
PBS. Cells were mixed with dsRNA/POA complex in a volume of 500
ll and these mixtures were shaken (100 rpm) for 1 h at 25 C. Then, 3
ml of fresh MS medium (free of dsRNA) containing 50 lgml1
kanamycin was added and incubated for the designated periods. As the
controls, cells treated with PBS only, POA only (10 lg), and dsRNA
only (20 lg) were included. All the PTGS experiments were done at
least three times to conﬁrm the results.
The viability of the treated cells was measured by 3-(4,5-dim-
ethyldiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) calorimetric
assay after 3-week of treatment. To the equal amount of cells (ca. 1 g)
20 ll of MTT (5 mgml1) in PBS buﬀer was added and incubated at 25
C for 5 h. Later, cells were sonicated and 50 ll of lysis solution (20%
SDS, 50% dimethyl formamide) was added and incubated for 2 h in the
dark at room temperature. After the incubation, the cell suspension
was centrifuged and the supernatant measured at 570 nm.Fig. 1. Localization of FITC-POA and FITC-dsRNA. 3-day-old tobacco
complexed with FITC-dsRNA (GUS) for 1 h (B) or 16 h (C), and localizatio2.6. RT-PCR
Total RNA was prepared from the samples using TRI reagent
(Molecular Probes Diagnostics, USA) following the manufacturer’s
instructions. After the medium was removed, cells were homogenized
with 1 ml of TRI reagent. To the homogenized cell suspension,
bromochloro propane was added. Following incubation for 15 min,
the mixture was centrifuged at 12 000g for 15 min. The RNA from
the aqueous phase was precipitated with isopropanol. About 5 lg of
total RNA was used to prepare cDNA using a RevertAidTM First
Strand cDNA Synthesis Kit (Fermentas, Lithuania). Oligo(dT)18
primers were used for cDNA synthesis. 5 ll of cDNA was ampliﬁed
for 30 cycles at 58 C as the annealing temperature. The primers used
were the same as those used to prepare the templates for the dsRNA.
5 ll of each ampliﬁed fragment was analyzed on a 1% agarose gel
electrophoresis.
2.7. Detection of siRNA by RNase protection assay
Total RNA was prepared from cells with TRI reagent as described
above with slight modiﬁcations. Total RNA was precipitated with
yeast tRNA and ethanol for 30 min at )70 C, dissolved in DEPC-
treated water. The small size RNA was enriched [27] and it was used
for the RNase protection assay [28]. In brief, the enriched small RNA
was hybridized to [a-32P]UTP-labeled sense-strand RNA (ssRNA) (the
900-bp RNA which corresponds to the internal region of GUS)
overnight at 35 C. siRNA in the enriched fraction binds to the ssRNA
during this period. The unhybridized single-stranded RNA was di-
gested with 40 lgml1 RNase A and 500 U RNase T1 (Ambion, USA)
in RNA digestion buﬀer (300 mMNaCl, 10 mM Tris–Cl at pH 7.4 and
5 mM EDTA at pH 7.5) at 37 C for 1 h. The reaction was stopped by
adding 20 ll of 10% SDS and 10 ll of proteinase K, and incubated at
30 C for 30 min. The mixture was puriﬁed with phenol–chloroform
and precipitated with yeast tRNA at )70 C for 30 min, followed by
fractionation on a 15% denaturing PAGE gel and exposure to X-ray
ﬁlm for 24 h. In vitro-prepared small 21-nucleotide antisense RNA was
used for the marker.3. Results
3.1. Localization of FITC-POA and FITC-dsRNA into cells
Prior to delivery of dsRNA into tobacco cells, localization of
both FITC-labeled dsRNA (FITC-dsRNA) and FITC-POA
was examined (Fig. 1). It was observed that FITC-POA was
located near the nuclear membrane and within the nucleus (A).
POA and FITC-dsRNAwere allowed to form a complex before
being delivered into cells. The FITC ﬂuorescence of dsRNAwas
shown to gradually disperse from the nuclear membrane (B) to
the cytoplasm (C). Since PTGS is likely to take place in the
cytoplasm where mRNA is localized, overnight incubation of
dsRNA was thought to be suitable to initiate PTGS. It was also
noted that dsRNA was not transported to the nucleus, as FITC
ﬂuorescence was not observed there (C).suspension cells were incubated with FITC-POA (A), or with POA
n of FITC ﬂuorescence was observed with a ﬂuorescence microscope.
Fig. 3. PTGS of GUS and NPTII mRNA in POA/dsRNA-treated
cells. For Northern blot analysis, total RNA (20 lg) prepared from
cells treated with POA/dsRNA (GUS) was probed with 32P-labeled
0.1-kb EcoRV fragment within GUS coding region (A). RT-PCR
analysis of GUS mRNA (B). Diﬀerent amounts of dsRNA (GUS)
were treated for 24 h to examine degradation of GUS mRNA: lane 1,
no dsRNA treatment; lane 2, POA alone; lane 3, dsRNA alone; lanes
4–7, 1, 5, 10 and 20 lg dsRNA complexed with POA, respectively. The
EtBr stain of rRNA is shown. RT-PCR analysis of NPTII mRNA (C).
Diﬀerent amounts of dsRNA (NPTII) were treated for 72 h to examine
degradation of NPTII mRNA. Lanes equivalent as in (B), dsRNA
(NPTII) instead of dsRNA (GUS). Longevity of PTGS (D). To ex-
amine duration of PTGS, cells were exposed to 20 lg dsRNA (GUS)
for 1 h, followed by further incubation in the absence of dsRNA for 1
(lane 2), 2 (lane 3) and 3 (lane 4) weeks (lane 1, 3-week incubation of
the POA-only control).
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To establish the optimum amount of the POA needed for
interacting dsRNA (GUS), various concentrations of POA
were mixed with dsRNA (GUS) to form a complex, as de-
scribed in Section 2, and these mixtures were subjected to 1%
agarose gel electrophoresis to examine the mobility retarda-
tion. As the amount of POA increased, the mobility of the
dsRNA decreased (Fig. 2), indicating that dsRNA was com-
plexed with POA. It was also noted that ethidium bromide
(EtBr) staining of the dsRNA also weakened as the POA
concentration increased. When 100 ng of dsRNA and 50 ng of
POA were mixed, there was no EtBr staining, strongly sug-
gesting that dsRNA was protected by POA (lane 9). This
suggestion was further supported by the observation of reap-
pearance of staining after addition of b-mercaptoethanol (lane
10), which disrupted the interaction between dsRNA and POA
to allow dsRNA to move equivalent to free dsRNA (lane 1).
This structure was proposed in the complexes of DNA and
cationic oligopeptides in general [26].
Scaling up the ratio used in lane 9, 20 lg dsRNA (GUS) and
10 lg POA were mixed and were allowed to interact for 30 min
in 500 ll PBS in most of the experiments unless otherwise
speciﬁed. It was assumed that all the dsRNA was bound to
POA in the complex-forming condition mentioned above,
since no free-dsRNA was detected after forming the complex
(data not shown). Several repeated experiments showed that
20 lg dsRNA, complexed with POA, was suﬃcient to induce
PTGS in approximately 1 g of tobacco suspension cells in 3 ml
total volume (34 pM of dsRNA).
3.3. Induction of PTGS
To investigate if dsRNA/POA (GUS or NPTII) induces
PTGS, we examined the degradation of the corresponding
mRNAs in cells treated with a given dsRNA (Fig. 3). To si-
lence GUS, various amounts of dsRNA (GUS), complexed
with POA, were incubated with cells for 24 h. Northern blot
analysis showed that 20 lg of dsRNA appeared to be suﬃcient
to degrade GUS mRNA completely (Fig. 3A). RT-PCR results
gave the similar results (Fig. 3B). NPTII mRNA appeared to
be stable during dsRNA (GUS) treatment (Fig. 3B), indicating
that dsRNA degradation was speciﬁc. In an equivalent way,
when dsRNA(NPTII) was delivered, NPTII mRNA was de-
graded and GUS mRNA unaﬀected (Fig. 3C). 10 lg of
dsRNA (NPTII) appeared to degrade mRNA (NPTII) com-
pletely within 72 h (Fig. 3C). It was also shown that the POA-,Fig. 2. Formation of POA/dsRNA complex. dsRNA (GUS) was
complexed with POA as described in Section 2 and was analyzed on a
1% agarose gel to determine the optimum POA concentration for the
probable penetration-eﬀective complex: lane 1, 100 ng dsRNA (GUS);
lane 2, POA alone (50 ng); lanes 3–9: 5, 10, 15, 20, 25, 37.5 and 50 ng of
POA mixed with dsRNA; lane 10, same as lane 9 except including b-
mercaptoethanol in the loading dye.dsRNA- or PBS-alone controls did not aﬀect both GUS and
NPT II mRNAs.
Many PTGS studies have used transformed plants in which
dsRNA was stably formed by chromosome-integrated inverted
repeat DNA construction. Since dsRNA was added exoge-
nously in this study, it was assumed that PTGS would be
transiently expressed according to the presence of dsRNA in
the cells, expecting that silenced target mRNA appeared again
as dsRNA disappeared. After dsRNA (GUS) treatment for
1 h, there was no indication of the reappearance of GUS
mRNA, suggesting that the PTGS lasted for at least 3 weeks.
Gentle shaking and medium changes every 5 days prevented
cells from deterioration, as evidenced by MTT cell viability
assay (data not shown). It was found that there was no indi-
cation of re-appearance of GUS mRNA (Fig. 3D), suggesting
that PTGS lasted for at least 3 weeks. NPTII mRNA was
unaﬀected during this period (Fig. 3D), further suggesting that
cells had maintained viability during this time. Both GUS and
NPT II mRNAs appeared to be persistent in the POA-treated
control cells that were grown also for three weeks (Fig. 3D).
3.4. Formation of siRNA
We further substantiated the occurrence of PTGS by
showing the presence of siRNA using RNase protection assay.
siRNA, corresponding to the 21-nt marker, was detected only
Fig. 4. siRNA detection by RNase protection assay. Cell was treated
with dsRNA (GUS) and total RNA was prepared. The enriched small
RNA fraction was hybridized to the 32P-labeled sense strand of GUS.
Unhybridized single strand portion of probe was removed by ssRNA-
speciﬁc RNaseA and remaining siRNA was detected by autoradio-
gram: lane 1, 21-nt marker; lane 2, PBS-only; lane 3, cells treated with
dsRNA alone and lane 4, cells treated with dsRNA/POA.
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dsRNA-alone control (Fig. 4). We have thus demonstrated
that POA delivered dsRNA eﬀectively and conveniently to
induce PTGS in tobacco suspension cells.4. Discussion
In this study, we observed eﬃcient silencing of GUS and
NPTII genes by the respective dsRNA complexed with POA.
POA eﬃciently delivered the dsRNA into tobacco cells to in-
duce PTGS. It is likely that delivery of dsRNA can be im-
proved by altering lengths and/or amino acid make-up of the
peptides. It was suggested that the longer polypeptides have so
many positive charges interacting with the mRNA that the
complexes are too tight to dissociate inside the cell [29]. It was
also suggested that small peptides with only 12–16 positive
charges released DNA easily in the cells [29]. These notions
may explain that POA, composed of 12 arginines, is an eﬃ-
cient carrier of dsRNA.
The prolonged PTGS in dsRNA/POA-treated cells suggests
that silencing was spread from silenced to non-silenced cells. It
is also likely that ampliﬁcation of siRNA by RdRp by repeated
rounds of dsRNA synthesis [30] may be the cause of the ob-
served prolonged silencing. The probable correlation between
RdRp activity and longevity of PTGS is presently being in-
vestigated.
Although PTD has been widely used for gene delivery
mostly in animal cells, this technology has not been reported inplant studies. Our results showed that POA did not deteriorate
plant cells at least for 3 weeks in the growth condition used in
this study. It is suggested that one of the prevalent applications
of PTGS is to study the function of gene by degrading the
corresponding mRNA. If one can readily induce PTGS in
cells, PTGS can be a strong alternative to the widely used
methods such as T-DNA insertional mutagenesis. In view of
convenience of preparation and delivery of dsRNA, POA-
mediated PTGS technology may be applied to the studies of
functional genomics or some other biotechnological re-
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